BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The Life Raft Group - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://liferaftgroup.org
X-WR-CALDESC:Events for The Life Raft Group
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240819T120000
DTEND;TZID=America/New_York:20240819T120000
DTSTAMP:20260418T132637
CREATED:20240724T133110Z
LAST-MODIFIED:20240724T134516Z
UID:10000786-1724068800-1724068800@liferaftgroup.org
SUMMARY:Managing Side Effects of GIST Therapies
DESCRIPTION:The Life Raft Group has partnered with Mia Weiss\, MD of Washington University School of Medicine in St. Louis to present “Managing Side Effects of GIST Therapies” to GIST patients and caretakers on August 19\, 2024 at 12pm. During this virtual presentation\, Dr. Weiss will provide an overview of GIST treatments and their side effects as well as home management for each type of symptom and when to call the clinic. \n\n\nPlease email srothschild@liferaftgroup.org to submit a question ahead of the presentation.  \n\n\n\nPlease note that this webinar is not a substitute for your physician’s guidance and care.\nREGISTERAbout Our Presenter\n \nDr. Mia Weiss\nWashington University School of Medicine in St. Louis \nMia C. Weiss\, M.D. is a medical oncologist with clinical interest in the care of patients with localized and metastatic soft tissue and bone sarcomas. She works collaboratively with pathologists\, radiation oncologists\, and orthopedic surgeons to assess\, diagnose\, and treat these complex malignancies. She is a member of the American College of Physicians\, the American Society of Clinical Oncology\, and the Connective Tissue Oncology Society. Her research interests include clinical trial development to assess efficacy of novel therapies in the treatment of metastatic sarcoma to ultimately improve patient survival and quality of life. She has particular interest related to genomics in sarcoma and finding ways to elucidate which patients are more likely to respond to targeted therapy and why some do not. Dr. Weiss has published several articles during her fellowship which most recently included a review on the use of Tazemetostat in epithelioid sarcoma\, a novel epigenetic regulator and the first of its kind to be approved in a solid tumor. Additionally\, Dr. Weiss has a strong interest in establishing a continuing medical educational program for community based primary care physicians and surgeons related to sarcoma and the importance of referring patients with soft tissue masses to an oncologic surgeon and ideally\, a sarcoma center\, to ensure optimal outcomes for patients. Dr. Weiss looks forward to continuing a career devoted to patient care\, research\, and education. \nThank you to our Webinar Sponsors!
URL:https://liferaftgroup.org/event/managing-side-effects-of-gist-therapies/
CATEGORIES:Education,Events,Webcast
ORGANIZER;CN="Sara Rothschild":MAILTO:srothschild@liferaftgroup.org
END:VEVENT
END:VCALENDAR